NASHVILLE, Tenn.–(BUSINESS WIRE)–PathGroup, one of the largest private providers of pathology, clinical and molecular laboratory services in the United States, today announced that it has acquired Pathologists Bio-Medical Laboratories (PBM), a leading provider of pathology services based in Dallas.
The combination of Nashville-based PathGroup and PBM will lead to enhanced services and a broader menu of testing across their client base. The combined company will include more than 120 pathologists, representing every sub-specialty, creating one of the most comprehensive pathology networks in the country.
“This joining of forces expands PathGroup’s presence in one of our key markets, while also providing a platform of enhanced services for the current clients and patients of both companies,” said Ben W. Davis, M.D., President and Chief Executive Officer of PathGroup. “The dedication of PBM to their community, clients and patients, their culture of physician leadership, and their goal of providing state-of-the-art services all match PathGroup’s commitments and values. Both companies have provided superior pathology services for more than 50 years. We look forward to working with the industry-leading health systems and practices of PBM to continue providing these services.”
“PBM and PathGroup have similar histories of providing high-quality pathology services to patients, physicians and health systems,” said Peter A. Dysert, M.D., President of PBM. “Our like-minded cultures of physician leadership and private ownership will allow us to focus on what is best for the clients and patients we serve. We look forward to working with PathGroup and continuing to exceed the expectations of our hospitals and physician clients.”
The combined company will be comprised of more than 1,800 employees working with more than 75 hospitals and thousands of physicians across the U.S. to deliver quality lab testing and diagnostic results with unmatched responsiveness.
Founded in 1965, PathGroup is a premier provider of anatomic, clinical and molecular pathology services in the United States. Privately held and physician-centric, PathGroup works seamlessly with customers to provide superior diagnostic services – a vital link in the cycle of patient relationships. PathGroup uses the latest in proprietary and industry standard technology to deliver fast, accurate results. The company provides clients with the highest quality of services available, consistently exceeding the expectations of physicians, employees, payers, and most importantly, patients. One Lab; Total Service. PathGroup is owned by Pritzker Private Capital along with management. For more information, visit pathgroup.com.
About Pritzker Private Capital
Pritzker Private Capital acquires and operates middle-market companies based in North America with leading positions in the manufactured products, services and healthcare sectors. The firm’s differentiated, long-duration capital base allows for efficient decision-making, broad flexibility with transaction structure and investment horizon, and alignment with all stakeholders. Pritzker Private Capital builds businesses for the long term and is an ideal partner for entrepreneur and family owned companies. For more information, visit PPCPartners.com.